Causeway Therapeutics Limited
Manufacture of flat glass · Glasgow
ActiveUnited KingdomIncorporated 2015Private Limited Company
Documents & history
Available account evidence and business events. This is not a complete filing history or document library.
Accounts to 2025-10-31
IXBRL · 97 source facts · 16 selected values
Validation findingsXBRL valid
Accounts to 2025-10-31
IXBRL · 97 source facts · 16 selected values
Validation findings
XBRL valid
- Reporting period
- 2024-11-01 to 2025-10-31
- Extraction status
- complete
- Numeric facts
- 37
- Documents processed
- 1
- XBRL standards validation
- valid
- Filing-profile validation
- invalid
- Parser
- arelle 2.44.4
- Taxonomy
- FRS-102-2025-01-01.xsd
- Currency
- GBP
- Source identifier
- Prod224_2603_SC518335_20251031
- Source archive
- Accounts_Monthly_Data-March2026.zip
Extraction findings: filing rules invalid. These describe source processing, not an audit opinion on the company.
Accounts to 2024-10-31
IXBRL · 96 source facts · 16 selected values
Validation findingsXBRL valid
Accounts to 2024-10-31
IXBRL · 96 source facts · 16 selected values
Validation findings
XBRL valid
- Reporting period
- 2023-11-01 to 2024-10-31
- Extraction status
- complete
- Numeric facts
- 35
- Documents processed
- 1
- XBRL standards validation
- valid
- Filing-profile validation
- invalid
- Parser
- arelle 2.44.4
- Taxonomy
- FRS-102-2023-01-01.xsd
- Currency
- GBP
- Source identifier
- Prod224_2504_SC518335_20241031
- Source archive
- Accounts_Monthly_Data-April2025.zip
Extraction findings: filing rules invalid. These describe source processing, not an audit opinion on the company.
Accounts to 2023-10-31
IXBRL · 97 source facts · 14 selected values
Not assessedlegacy record
Accounts to 2023-10-31
IXBRL · 97 source facts · 14 selected values
Not assessed
legacy record
- Reporting period
- 2022-11-01 to 2023-10-31
- Extraction status
- Legacy / not assessed
- Numeric facts
- 37
- Documents processed
- Not recorded
- XBRL standards validation
- Not assessed
- Filing-profile validation
- Not assessed
- Parser
- Legacy parser
- Taxonomy
- FRS-102-2022-01-01.xsd
- Currency
- GBP
- Source identifier
- Prod224_2366_SC518335_20231031
- Source archive
- Accounts_Monthly_Data-July2024.zip
Accounts to 2022-10-31
IXBRL · 117 source facts · 16 selected values
Not assessedlegacy record
Accounts to 2022-10-31
IXBRL · 117 source facts · 16 selected values
Not assessed
legacy record
- Reporting period
- 2021-11-01 to 2022-10-31
- Extraction status
- Legacy / not assessed
- Numeric facts
- 57
- Documents processed
- Not recorded
- XBRL standards validation
- Not assessed
- Filing-profile validation
- Not assessed
- Parser
- Legacy parser
- Taxonomy
- FRS-102-2021-01-01.xsd
- Currency
- GBP
- Source identifier
- Prod224_0007_SC518335_20221031
- Source archive
- Accounts_Monthly_Data-March2023.zip
Accounts to 2021-10-31
IXBRL · 107 source facts · 18 selected values
Not assessedlegacy record
Accounts to 2021-10-31
IXBRL · 107 source facts · 18 selected values
Not assessed
legacy record
- Reporting period
- 2020-11-01 to 2021-10-31
- Extraction status
- Legacy / not assessed
- Numeric facts
- 46
- Documents processed
- Not recorded
- XBRL standards validation
- Not assessed
- Filing-profile validation
- Not assessed
- Parser
- Legacy parser
- Taxonomy
- FRS-102-2021-01-01.xsd
- Currency
- GBP
- Source identifier
- Prod224_0104_SC518335_20211031
- Source archive
- Accounts_Monthly_Data-March2022.zip
Accounts to 2020-10-31
IXBRL · 109 source facts · 18 selected values
Not assessedlegacy record
Accounts to 2020-10-31
IXBRL · 109 source facts · 18 selected values
Not assessed
legacy record
- Reporting period
- 2019-11-01 to 2020-10-31
- Extraction status
- Legacy / not assessed
- Numeric facts
- 48
- Documents processed
- Not recorded
- XBRL standards validation
- Not assessed
- Filing-profile validation
- Not assessed
- Parser
- Legacy parser
- Taxonomy
- FRS-102-2019-01-01.xsd
- Currency
- GBP
- Source identifier
- Prod224_0092_SC518335_20201031
- Source archive
- Accounts_Monthly_Data-July2021.zip
Accounts to 2019-10-31
IXBRL · 99 source facts · 16 selected values
Not assessedlegacy record
Accounts to 2019-10-31
IXBRL · 99 source facts · 16 selected values
Not assessed
legacy record
- Reporting period
- 2018-11-01 to 2019-10-31
- Extraction status
- Legacy / not assessed
- Numeric facts
- 38
- Documents processed
- Not recorded
- XBRL standards validation
- Not assessed
- Filing-profile validation
- Not assessed
- Parser
- Legacy parser
- Taxonomy
- FRS-102-2014-09-01.xsd
- Currency
- GBP
- Source identifier
- Prod224_0080_SC518335_20191031
- Source archive
- Accounts_Monthly_Data-July2020.zip
Accounts to 2018-10-31
IXBRL · 103 source facts · 16 selected values
Not assessedlegacy record
Accounts to 2018-10-31
IXBRL · 103 source facts · 16 selected values
Not assessed
legacy record
- Reporting period
- 2017-11-01 to 2018-10-31
- Extraction status
- Legacy / not assessed
- Numeric facts
- 42
- Documents processed
- Not recorded
- XBRL standards validation
- Not assessed
- Filing-profile validation
- Not assessed
- Parser
- Legacy parser
- Taxonomy
- FRS-102-2014-09-01.xsd
- Currency
- GBP
- Source identifier
- Prod224_0063_SC518335_20181031
- Source archive
- Accounts_Monthly_Data-February2019.zip
Accounts to 2016-10-31
IXBRL · 23 source facts · 2 selected values
Not assessedlegacy record
Accounts to 2016-10-31
IXBRL · 23 source facts · 2 selected values
Not assessed
legacy record
- Reporting period
- 2015-10-20 to 2016-10-31
- Extraction status
- Legacy / not assessed
- Numeric facts
- 6
- Documents processed
- Not recorded
- XBRL standards validation
- Not assessed
- Filing-profile validation
- Not assessed
- Parser
- Legacy parser
- Taxonomy
- uk-gaap-full-2009-09-01.xsd
- Currency
- GBP
- Source identifier
- Prod224_0044_SC518335_20161031
- Source archive
- Accounts_Monthly_Data-July2017.zip
Registered details
SC518335- Status
- Active
- Type
- Private Limited Company
- Incorporated
- 2015-10-20
- Jurisdiction
- —
- Registered office
- IMAGING CENTRE OF EXCELLENCE, QUEEN ELIZABETH UNIVERSITY HOSPITAL, GLASGOW, G51 4TF, SCOTLAND
Classification
1 SIC codes23110
Capital & company events
Reconstructed equity rounds and matched research funding.
Equity fundraising
1 SH01-derived rounds2025-06-20
£2,277,537 raised
£27,893,196 estimated post-money
Research and innovation
5 matched grantsOsteoMiR -- a novel disease-modifying drug for the treatment of osteoarthritis.Innovate UK · Study · 2021-01-01 – 2023-12-31 · with 1 other participant£0awarded
OsteoMiR -- a novel disease-modifying drug for the treatment of osteoarthritis.
Innovate UK · Study · 2021-01-01 – 2023-12-31 · with 1 other participant
£0
awarded
University of Glasgowlead£169,565
Causeway Therapeutics Limited£0
OsteoMiR -- a novel disease-modifying drug for the treatment of osteoarthritis.UKRI Inn.Scholar · Study · 2021-01-01 – 2023-12-31 · with 1 other participant£169,565whole project
OsteoMiR -- a novel disease-modifying drug for the treatment of osteoarthritis.
UKRI Inn.Scholar · Study · 2021-01-01 – 2023-12-31 · with 1 other participant
£169,565
whole project
University Of GlasgowleadCauseway Therapeutics Limited
A first-in-patient trial of TenoMiR a microRNA replacement therapy for tendinopathyLead
Innovate UK · Feasibility Studies · 2020-06-01 – 2020-11-30
£230,896
awarded
A first-in-patient trial of TenoMiR a microRNA replacement therapy for tendinopathy.Lead
Innovate UK · Collaborative R&D · 2019-07-01 – 2021-09-30
£1,228,273
awarded
microRNA therapy in tendon diseaseLeadInnovate UK · Collaborative R&D · 2018-05-01 – 2020-04-30 · with 1 other participant£1,308,892awarded
microRNA therapy in tendon diseaseLead
Innovate UK · Collaborative R&D · 2018-05-01 – 2020-04-30 · with 1 other participant
£1,308,892
awarded
Causeway Therapeutics Limitedlead£1,308,892